These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23282004)
1. Sodium N-(methylsulfonyl)-N-(4-nitro-2-phenoxyphenyl)sulfamate: a water-soluble nimesulide prodrug for parenteral use. Rapposelli S; Digiacomo M; Franchi S; Moretti S; Pinza M; Sacerdote P; Balsamo A Mol Pharm; 2010 Oct; 7(5):1871-6. PubMed ID: 23282004 [TBL] [Abstract][Full Text] [Related]
2. Hydrotropic solubilization of nimesulide for parenteral administration. Agrawal S; Pancholi SS; Jain NK; Agrawal GP Int J Pharm; 2004 Apr; 274(1-2):149-55. PubMed ID: 15072791 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives. Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activity and pharmacokinetic profile of a new parenteral formulation of nimesulide. Gupta SK; Bhardwaj RK; Tyagi P; Sengupta S; Velpandian T Pharmacol Res; 1999 Feb; 39(2):137-41. PubMed ID: 10072704 [TBL] [Abstract][Full Text] [Related]
5. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage. Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064 [TBL] [Abstract][Full Text] [Related]
6. Identification of 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-pyrazol-1-yl]-N-propionylbenzenesulfonamide sodium as a potential COX-2 inhibitor for oral and parenteral administration. Singh SK; Vobbalareddy S; Kalleda SR; Casturi SR; Datla SR; Mamidi RN; Mullangi R; Ramanujam R; Yeleswarapu KR; Iqbal J Bioorg Med Chem; 2006 Dec; 14(24):8626-34. PubMed ID: 16949828 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action. Choi HK; Chun MK; Lee SH; Jang MH; Kim HD; Jung CS; Oh SY Int J Pharm; 2007 Aug; 341(1-2):50-7. PubMed ID: 17517483 [TBL] [Abstract][Full Text] [Related]
8. Enhanced water-soluble derivative of PC407 as a novel potential COX-2 inhibitor injectable formulation. Liu HF; Wan N; Huan ML; Jia YY; Yuan XF; Zhou SY; Zhang BL Bioorg Med Chem Lett; 2014 Oct; 24(20):4794-7. PubMed ID: 25248683 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro evaluation of nimesulide-containing preparations on the Italian market. Butler D; Bonadeo D; Maroni A; Foppoli A; Zema L; Giordano F Boll Chim Farm; 2000; 139(6):237-41. PubMed ID: 11213426 [TBL] [Abstract][Full Text] [Related]
10. New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs. Almansa C; Bartrolí J; Belloc J; Cavalcanti FL; Ferrando R; Gómez LA; Ramis I; Carceller E; Merlos M; García-Rafanell J J Med Chem; 2004 Oct; 47(22):5579-82. PubMed ID: 15481993 [TBL] [Abstract][Full Text] [Related]
11. Comparison of suspension composition on the pharmacokinetics of nimesulide in rats. Carrasco-Portugal Mdel C; Flores-Murrieta FJ Proc West Pharmacol Soc; 2008; 51():58-9. PubMed ID: 19544678 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioavailability of nimesulide in goats. Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902 [TBL] [Abstract][Full Text] [Related]
13. Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations. Curcio A; Sasso O; Melisi D; Nieddu M; La Rana G; Russo R; Gavini E; Boatto G; Abignente E; Calignano A; Rimoli MG J Med Chem; 2009 Jun; 52(12):3794-800. PubMed ID: 19459639 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of nimesulide. Bernareggi A Clin Pharmacokinet; 1998 Oct; 35(4):247-74. PubMed ID: 9812177 [TBL] [Abstract][Full Text] [Related]
15. Anti-hyperalgesic effects of nimesulide: studies in rats and humans. Bianchi M; Broggini M Int J Clin Pract Suppl; 2002 Jul; (128):11-9. PubMed ID: 12166613 [TBL] [Abstract][Full Text] [Related]
16. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats. Choi JS; Shin SC Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561 [TBL] [Abstract][Full Text] [Related]
17. The influence of malnutrition on the oral pharmacokinetics of nimesulide in rats. Carrasco-Portugal Mdel C; Camacho-Vieyra AG; Flores-Murrieta FJ Proc West Pharmacol Soc; 2008; 51():52-4. PubMed ID: 19544676 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease. Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic profile of nimesulide in healthy volunteers. Bernareggi A Drugs; 1993; 46 Suppl 1():64-72. PubMed ID: 7506196 [TBL] [Abstract][Full Text] [Related]
20. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]